Increased neuroendocrine tumours, but small colorectal cancer incidence in patients with inflammatory bowel disease treated by mesalazine
No abstract available
Source: European Journal of Gastroenterology and Hepatology - Category: Gastroenterology Tags: Letters to the Editor Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Colorectal Cancer | Gastroenterology | Inflammatory Bowel Disease | Neurology